In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Fate Therapeutics Inc (NASDAQ: FATE) closed at $1.25 down -2.71% from its previous closing price of $1.29. In other words, the price has decreased by -$2.71 from its previous closing price. On the day, 4.33 million shares were traded. FATE stock price reached its highest trading level at $1.31 during the session, while it also had its lowest trading level at $1.04.
Ratios:
For a deeper understanding of Fate Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.29 and its Current Ratio is at 8.29. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.25.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 10 ’25 when Bressi Jerome Charles sold 5,980 shares for $1.55 per share. The transaction valued at 9,269 led to the insider holds 270,203 shares of the business.
TAHL CINDY sold 5,654 shares of FATE for $8,764 on Jan 10 ’25. The insider now owns 336,707 shares after completing the transaction at $1.55 per share. On Jan 10 ’25, another insider, Valamehr Bahram, who serves as the President and CEO of the company, sold 8,705 shares for $1.54 each. As a result, the insider received 13,406 and left with 349,364 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 142936976 and an Enterprise Value of -55004612. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.63 while its Price-to-Book (P/B) ratio in mrq is 0.39. Its current Enterprise Value per Revenue stands at -4.09 whereas that against EBITDA is 0.334.
Stock Price History:
Over the past 52 weeks, FATE has reached a high of $8.83, while it has fallen to a 52-week low of $1.28. The 50-Day Moving Average of the stock is -41.58%, while the 200-Day Moving Average is calculated to be -64.46%.
Shares Statistics:
For the past three months, FATE has traded an average of 3.11M shares per day and 3062830 over the past ten days. A total of 113.88M shares are outstanding, with a floating share count of 97.96M. Insiders hold about 13.99% of the company’s shares, while institutions hold 89.17% stake in the company. Shares short for FATE as of 1735603200 were 11195194 with a Short Ratio of 3.60, compared to 1732838400 on 11348453. Therefore, it implies a Short% of Shares Outstanding of 11195194 and a Short% of Float of 11.2799995.
